5. Lets have a quick exercise
to create opportunity of
discussion and reduce the
barriers in journey of
learning
6. 0418 RO 2017 PHR
April 2018 RO Experience Subject
Total
Searle
Pharmacy - PHR
Business - BLG
Engineering - ENG
Allied Sciences - AHS
Chemistry - CHM
Microbiology - MCB
0418-RO-2017-PHR
7. This presentation discusses Regulatory Science,
nothing more & nothing less
Reference: US-FDA Documents / Scientific Articles
Personal point of view & nothing to disclose
Disclaimer
26. …. Lets have a deep breath and see ….
Who we are, What we do, What can go wrong &
Where we have to focus
It’s a matter of human life, it’s a matter of your
own progress & progress of company
27. …. Lets have a deep breath and see ….
Who we are, What we do, What can go wrong &
Where we have to focus
It’s a matter of human life, it’s a matter of your
own progress & progress of company
28. What will happen if we don’t have Penicillin?
What Penicillin did
Horrible death & Fear across
29. What will happen if we don’t have cardiovascular drugs?
E.g. What Captopril did
Life Crisis
30. What will happen if we don’t have drugs for Diabetes?
E.g. What sulfonylureas did?
Death Penalty
31. What will happen if we don’t have drugs for Psychiatry?
E.g. What haloperidol did?
Social Crisis
32. What will happen if we don’t have drugs for Asthma?
E.g. What salbutamol did?
Breath Crisis
33. …. Lets have a deep breath and see ….
Who we are, What we do, What can go wrong &
Where we have to focus
It’s a matter of human life, it’s a matter of your
own progress & progress of company
39. If it happened in Pakistan, were me & you able
to catch?
What do you think can it be caught in testing?
Do you think we are capable to catch such level
of contaminant or less?
No
Yes
Don’t
know
49. Efficacy
The drug is overheated in the dryer. What do you think?
Should it go to the market
50. Cleaning
An equipment is cleaned but not properly cleaned after
manufacturing of a male hormone. Time is not available
and you have to manufacture female hormone in the
same equipment.
What decision you think appropriate?
62. Beta-lactam &
cephalosporin
Personnel can freely move
for collecting samples and
engaging in other
activities
Failed to monitor
surface sampling for
residual traces
Ranbaxy Laboratories Ltd, India
63. Tab Tramadol
contaminated with
Metoprolol HCl (19
Feb 2008)
Tablet Metoprolol
contaminated with
Metformin (25 Feb
2008)
The investigation
was limited to
Tramadol tab after 2
months
Investigation was
not extended to
closely related …
confirm incident
Other potential
impact was not given
priority
Source of
contamination was
neither isolated nor
confirmed
Continued releasing
of drug product at
the same time
……..
Story ended up with
regulatory actions
Caraco Pharmaceutical Laboratories, USA
64. Material contaminated with
tank (a waste tank of API,
Intermediates & Solvents)
Aware in Jan
2012
Complete risk
assessment in
April 2013
In b/w assessment
you distributed
the batches
Some batches
were rejected
Assessment
approaches used
were different
Ended up with
warning
letters
GSK, Cork, Ireland
65. 2001-2005
750m $ Mix up Too much or too
little API
Contamination
A number of products, tablet, cream,
control release etc.
66. GMP failures,
Establishment of
contamination
A number of products were
questionable
Matter expanded to
criminal investigation
Story ended up in payment
of $750 million for bad
products manufactured in a
plant that was live with
contamination for years
GSK, Peurto Rico
69. Safe, efficacious & have correct
identity
Deliver the same performance as
claimed
Perform consistently over shelf
life
Made in a manner that ensure
quality
Will be available when needed
Patient and
Doctor
assume that
Drugs are
75. No
Anti-microbial effectiveness test
Preservative must not be used as a substitute to GMP
Appropriate procedure to prevent objectionable
microorganisms in non-sterile products
Preservative is to reduce the viable microbial
population
76. No
Preservative may not be used to reduce initial OOS
result
Failure to meet established conditions must be
rejected
Preservative is used to reduce bio-burden of a multi-
dose formulation
Rejection is not an option but obligation
77. No
… to reduce microorganisms introduced during
manufacturing by addition of preservative
It is an opportunity to see & review manufacturing
process & identify the weakest area
Holding for 2 weeks is a great question that provides
opportunity …
Look back & see desensitization of Quality
Management System
80. Defined as the
shared beliefs, values,
attitudes, and behavior
patterns that characterize
the members of an
organization.
CULTURE
81. Quality Culture
It starts with leadership that
understands that human behavior and
motivations are critical to meeting
ongoing quality requirements, and
naturally emphasizes continuous
improvement of processes
104. Expectation of Regulatory Agency from Manufacturer
Extensive
knowledge of
Critical products
Process parameters
Quality attributes
105. Be clear about ….. Role of Regulatory Agency
Verification & audit to
Keep
manufacturing
supplements /
variations
minimum
106. Recap: Why Quality Metrics?
Improves process performance
Continuous improvement in PQS
Improves product quality
Increased operational excellence
Important element of oversight
107. Quality Metrics ultimately leads to
QM
leads to
Patient access to
reliable therapies
Fewer drug shortageFewer recalls
108. Key Focus of Regulatory Agency
Robustness of
Manufacturing
process
Lot
Acceptance
Rate Robustness of
Lab
Operations
Invalidated
OOS Rate
Voice of
customer/
patient
Product
Quality
Complaint
Rate
109. Further Emphasis of Regulatory Agency
Process capability
& performance
Quality culture
CAPA
effectiveness
Meeting PQS
timeframes
Senior
management
commitment to
quality
110. Cultural Scores & Site Performance Key Quality Metrics
Pharmaceutical OnlineKen Congdon, 26 May 2015
Stronger culture is correlated with
fewer action limit excursions in steriles
1/4 ISPE
111. Cultural Scores & Site Performance Key Quality Metrics
Pharmaceutical OnlineKen Congdon, 26 May 2015
Stronger culture scores are associated
with higher lot acceptance
2/4 ISPE
112. Cultural Scores & Site Performance Key Quality Metrics
Pharmaceutical OnlineKen Congdon, 26 May 2015
Sites with higher quality culture scores
have lower deviations recurrence
3/4 ISPE
113. Cultural Scores & Site Performance Key Quality Metrics
Pharmaceutical OnlineKen Congdon, 26 May 2015
Sites with higher quality culture scores
have higher CAPA effectiveness
4/4 ISPE
114. Identified Essential Attributes for Culture of Quality
Harvard Business ReviewSurvey April 2014
Leadership Emphasis
Message Credibility
Peer Involvement
Employee Ownership
115. Identified Essential Attributes for Culture of Quality
Harvard Business ReviewSurvey April 2014
Maintaining a leadership emphasis on quality
What they say & What they do
1/4
116. Even when executives have the best intentions, there are
often gaps b/w
What they say & What they do
As a result, employees get mixed messages about whether
quality is truly important. Company leaders must first buy
into quality improvement initiatives and clearly
demonstrate their own personal commitment to this effort
to employees
117. Identified Essential Attributes for Culture of Quality
Harvard Business ReviewSurvey April 2014
Ensuring Message Credibility
One Message
2/4
118. Quality messaging should be tailored in such a
way that it resonates with every employee.
Different messages may need to be developed to
resonate appropriately with employees at
different sites.
The key is to regularly test these messages with
employees, solicit their feedback, and refresh
these messages over time if necessary
119. Identified Essential Attributes for Culture of Quality
Harvard Business ReviewSurvey April 2014
Encouraging Peer Involvement
Participation
3/4
120. A variety of different tactics can be used to
create positive social pressure that encourages
employees to participate in (& even generate)
quality initiatives. These can include friendly
“quality competitions”.
The key is to test these tactics and solicit
feedback to see which are most effective with
employees.
121. Identified Essential Attributes for Culture of Quality
Harvard Business ReviewSurvey April 2014
Increasing Ownership & Empowerment
Engage in Decisions
4/4
122. Employees should be free to apply their own
judgment to situations that fall outside the
common directive but within frame of approved
procedure & authority. Providing the right level of
guidance & training is crucial to this effort
Remember, they must know how to act when they
encounter specific quality issues.
123. Visible Signals of Quality Culture
Right tone at the top
Focus on the right
value
Constant display of
putting patient
above everything
Constant display of
concern for quality
Consistently
walks the talk
With great
people skill
& strong
value
More than
financial
rewards
124. Roots of Strong Quality Culture
Introduction of Improvement & Innovation for quality driven
productivity
Adaptation & Investment in Technology to ensure state of control
over system
Promotion of change & continuous improvement in Quality
System
125. Roots of Strong Quality Culture
Prompt adaptation of best practice, low staff rotation
Proactive & transparent behavior
Strong relationship based on dialogue, science & mutual respect
126. Principle of Quality Culture
Product & Process Understanding Sensible Business Management
Sufficient depth of science to
explain why deviations have
not impacted on quality of
product
Too fast growth & operating at
limit of capacity triggers often
issues & non-compliance
127. How mature is your quality system
1 2 3 4
Level
Richard L. Friedman, FDLI Workshop Washington DC, July 2014US-FDA
Small problems ultimately snowball into larger ones, and
management becomes aware only when there is a crisis
128. How mature is your quality system
1 2 3 4
Level
Richard L. Friedman, FDLI Workshop Washington DC, July 2014US-FDA
Nearly always reactive, but there is willingness to change.
Patchwork corrections are the norm
129. How mature is your quality system
1 2 3 4
Level
Richard L. Friedman, FDLI Workshop Washington DC, July 2014US-FDA
More proactive. Increasingly detects emerging adverse trends,
surfaces major issues, and makes lasting manufacturing and
system improvements
130. How mature is your quality system
1 2 3 4
Level
Richard L. Friedman, FDLI Workshop Washington DC, July 2014US-FDA
Routinely acts preventively as described in level 3. Fully
institutionalizes and reinforces (rewards) a vigilant culture that
makes meaningful manufacturing and systemic improvements
131. Systems Thinking
System is the product of interacting parts
Improving the parts taken separately will
not improve the system
132. Quality is everyone’s responsibility
Selected Quotes, W. Edwards Deming
Lack of
knowledge …
that is the
problem
If you do not
know how to ask
the right
question, you
discover nothing
If you can’t describe
what you are doing as
a process, you don’t
know what you are
doing
Rational behavior
requires theory.
Reactive behavior
requires only reflex
action
Whenever there
is fear, you will
get wrong
figures
Learning is not compulsory … neither is survival
133. Strong Quality Culture Efficient Quality System Consistent manufacturing
It’s the culture that decides the path
Poor Quality Culture Unreliable Quality System Defects and Recall
141. Me, my kids &
parents use same
drug which I
manufacture
No batch has ever
failed
142. Drug manufactured in non-cGMP
environment
It does not mean that there is necessarily
something wrong with the drug
But “intention in question”
143. Please remember
Lack of adverse event reports, or
“something is wrong” is NOT the same
as evidence of no harm….
145. Innocence
• Quality
mainly
outsourced
to regulators
Awareness
• Quality unit
will identify
the issue
Understanding
• Quality
system &
Metrics
reveals
reality &
drives action
Competence
• Quality
mind set in
all functions.
Design
quality in &
anticipate
issues
Excellence
• Competitive
advantage
through
prevention
of quality
issues
Journey of uncertainty to certainty matters
151. C
A
P
A
B
I
L
I
T
I
E
S
Patient
Focus
I know which parameters of our products are
particularly important for patients
The training I have received clearly helps me to
ensure quality in the end product
Training
Problem
solving
All line workers are regularly involved in problem
solving, trouble shooting & investigations
152. G
O
V
E
R
N
A
N
C
E
Recognition
We recognize and celebrate both individual &
group achievements in quality
Up-to-date quality metrics (defects, rejects,
complaints) are posted & easily visible in line
We are regularly tracking variations in process
parameters & using them to improve the processes
Metrics
Knowledge
Continuous
Improvement
Each worker can explain what line quality
information is tracked & why
153. L
E
A
D
E
R
S
H
I
P
Coaching
Supervisors provide regular & sufficient support &
coaching to line workers to help them improve quality
We have daily quality metrics reviews & quality
issues discussions on the shop floor
Dialogue
Gemba
Management is on the floor several times a day both
for planned meetings & also to observe & contribute
to the daily activities
154. M
I
N
D
S
E
T
Awareness
Every line worker is aware of the biggest quality
issue on their line & what is being done about
them
All employees see quality & compliance as
their personal responsibility
Responsibility
155. I
N
T
E
G
R
I
T
Y
Openness
I am not afraid to bring quality issues to the
management’s attention
People I work with do not exploit to their advantage
inconsistencies or “grey areas” in procedures
Ethics
Motivation
All employees care about doing good job & go the
extra mile to ensure quality